Geode Capital Management’s Lakewood-Amedex Biotherapeutics LABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$42.8K Buy
+44,800
New +$99.3K ﹤0.01% 4232

Other funds holding LABT

Geode Capital Management's LABT Position: Q3 2026 in Review

Geode Capital Management opened a new position in Lakewood-Amedex Biotherapeutics (LABT) in Q3 2026: 44,800 shares worth $42.8K. The stake represents ﹤0.01% of the portfolio and ranks #4232 among its holdings.

7 funds tracked by Wall St. Rank hold LABT as of Q3 2026.

  • Geode Capital Management held 44,800 shares of Lakewood-Amedex Biotherapeutics worth $42.8K as of Q3 2026.
  • Lakewood-Amedex Biotherapeutics was a new Geode Capital Management position in Q3 2026.
  • Lakewood-Amedex Biotherapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4232 holding.
  • 7 funds tracked by Wall St. Rank held Lakewood-Amedex Biotherapeutics as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.